| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| T S Gray, M D Cassell, G Nilaver, E A Zimmerman, T H William. The distribution and ultrastructure of VIP-immunoreactivity in the central nucleus of the rat amygdala. Neuroscience. vol 11. issue 2. 1984-05-30. PMID:6717798. |
vasoactive intestinal polypeptide (vip) neurons within the central nucleus of the rat amygdala were examined using light and electron microscopic immunocytochemical techniques. |
1984-05-30 |
2023-08-12 |
rat |
| I N Ferrier, A J Cross, J A Johnson, G W Roberts, T J Crow, J A Corsellis, Y C Lee, D O'Shaughnessy, T E Adrian, G P McGrego. Neuropeptides in Alzheimer type dementia. Journal of the neurological sciences. vol 62. issue 1-3. 1984-04-25. PMID:6199464. |
five neuropeptides (cholecystokinin (cck), vasoactive intestinal polypeptide (vip), somatostatin (srif), neurotensin (nt) and substance p (sp)) were measured in 14 brain areas (4 cortical areas, hippocampus, amygdala, 3 striatal areas, 2 thalamic areas and 3 subcortical areas-- septum, substantia innominata and hypothalamus) in 12 brains with neuropathologically confirmed alzheimer type change and in 13 control brains. |
1984-04-25 |
2023-08-12 |
cat |
| G W Roberts, I N Ferrier, Y Lee, T J Crow, E C Johnstone, D G Owens, A J Bacarese-Hamilton, G McGregor, D O'Shaughnessey, J M Pola. Peptides, the limbic lobe and schizophrenia. Brain research. vol 288. issue 1-2. 1984-03-14. PMID:6198024. |
significant (p less than 0.05) differences between groups were: reductions of cck and som in hippocampus and cck in amygdala in type ii schizophrenics, and cck in the temporal cortex of the total schizophrenic group; and elevations of vip in amygdala in type i schizophrenics and of sp in the hippocampus in the total schizophrenic group. |
1984-03-14 |
2023-08-12 |
human |
| T S Gray, M D Cassell, T H William. Synaptology of three peptidergic neuron types in the central nucleus of the rat amygdala. Peptides. vol 3. issue 3. 1982-12-02. PMID:6126863. |
the synaptology of neurotensin (nt)-, somatostatin (ss)- and vasoactive intestinal polypeptide (vip)-immunoreactive neurons was studied in the central nucleus of the rat amygdala (cna). |
1982-12-02 |
2023-08-12 |
rat |
| J Besson, W Rotsztejn, B Poussin, A M Lhiaubet, G Rosseli. Release of vasoactive intestinal peptide from rat brain slices by various depolarizing agents. Neuroscience letters. vol 28. issue 3. 1982-07-08. PMID:6123097. |
the release of vasoactive intestinal peptide (vip) from rat brain cortical and amygdala slices was studied by using various depolarizing agents such as potassium (k+), veratridine (ver) and batrachotoxin (btx). |
1982-07-08 |
2023-08-12 |
rat |
| J Besson, W Rotsztejn, B Poussin, A M Lhiaubet, G Rosseli. Release of vasoactive intestinal peptide from rat brain slices by various depolarizing agents. Neuroscience letters. vol 28. issue 3. 1982-07-08. PMID:6123097. |
maximal stimulation obtained with 56 mmk+, 50 microm ver and 1 microm btx corresponds to a mean 3-fold increase above the basal release of vip in both cortex and amygdala. |
1982-07-08 |
2023-08-12 |
rat |
| G W Roberts, P L Woodhams, M G Bryant, T J Crow, S R Bloom, J M Pola. VIP in the rat brain: evidence for a major pathway linking the amygdala and hypothalamus via the stria terminalis. Histochemistry. vol 65. issue 2. 1980-05-23. PMID:7358518. |
vip in the rat brain: evidence for a major pathway linking the amygdala and hypothalamus via the stria terminalis. |
1980-05-23 |
2023-08-12 |
rat |
| G W Roberts, P L Woodhams, M G Bryant, T J Crow, S R Bloom, J M Pola. VIP in the rat brain: evidence for a major pathway linking the amygdala and hypothalamus via the stria terminalis. Histochemistry. vol 65. issue 2. 1980-05-23. PMID:7358518. |
although the functional significance of vip in the brain is unknown, its presence in the amygdala, the hypothalamus and their linking pathway, as well as its pharmacological actions suggest that it may play a role in neuroendocrine regulation and the modulation of hypothalamic function. |
1980-05-23 |
2023-08-12 |
rat |
| K B Sims, D L Hoffman, S I Said, E A Zimmerma. Vasoactive intestinal polypeptide (VIP) in mouse and rat brain: an immunocytochemical study. Brain research. vol 186. issue 1. 1980-05-14. PMID:6986955. |
at least 4 different major vip systems were found: (1) an intracerebral cortical system; (2) one innervating the central amygdala and nucleus of the stria terminalis; (3) a pathway originating in the suprachiasmatic nucleus of the hypo thalamus; and (4) another originating in the central grey of the midbrain. |
1980-05-14 |
2023-08-12 |
mouse |
| J Epelbaum, L Tapia-Arancibia, J Besson, W H Rotsztejn, C Kordo. Vasoactive intestinal peptide inhibits release of somatostatin from hypothalamus in vitro. European journal of pharmacology. vol 58. issue 4. 1980-02-15. PMID:510382. |
vip induced a dose-dependent inhibition of srif release from mediobasal hypothalamic slices but did not interfere with srif release from preoptic area, amygdala or cortex. |
1980-02-15 |
2023-08-11 |
rat |
| M Quik, P C Emson, J Fahrenkrug, L L Iverse. Effect of kainic acid injections and other brain lesions on vasoactive intestinal peptide (VIP)-stimulated formation of cAMP in rat brain. Naunyn-Schmiedeberg's archives of pharmacology. vol 306. issue 3. 1979-10-24. PMID:38409. |
the results suggest that vip may be involved in neuromodulation or neurotransmission in the striatum and/or nigrostriatal pathway and also in the stria terminalis from the bed nucleus to the amygdala. |
1979-10-24 |
2023-08-11 |
rat |
| W K Samson, S I Said, S M McCan. Radioimmunologic localization of vasoactive intestinal polypeptide in hypothalamic and extrahypothalamic sites in the rat brain. Neuroscience letters. vol 12. issue 2-3. 1979-09-27. PMID:460720. |
highest concentrations of vip were found in cerebral cortex, suprachiasmatic nucleus, and medial amygdaloid nucleus. |
1979-09-27 |
2023-08-11 |
rat |